mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |